Showing results (71-80 of 376) with videos related to

Sort By:
Pageof 38
Gastroenterology|May 15, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Inflammatory Bowel Disease: Expert ReviewSahil Khanna, Jessica R Allegretti, Jana G Hashash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2019
Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysisRaseen Tariq, Darrell S Pardi, Mark G Bartlett, et al.
Gastroenterology|May 16, 2024
The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and BeyondJessica R Allegretti, Sahil Khanna, Benjamin H Mullish, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 23, 2023
Reduction in urinary tract infections in patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infectionRaseen Tariq, Pritish K Tosh, Darrell S Pardi, et al.
The Journal of Infectious Diseases|June 17, 2026
When Does Clostridioides difficile "Recur"? Reconcile Epidemiologic & Bedside Recurrent CDI definitionsSahil Khanna, Paul Feuerstadt, Jessica R Allegretti, et al.
JCO Oncology Practice|February 13, 2020
Management of Cancer Therapy-Associated Oral MucositisTimothy J Brown, Arjun Gupta
Clinical Kidney Journal|June 13, 2015
Epstein-Barr virus-associated nephrotic syndromeDeana Mikhalkova, Sahil Khanna, Rakhee Vaidya, et al.
Infectious Diseases and Therapy|December 21, 2022
Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile InfectionErik R Dubberke, Robert Orenstein, Sahil Khanna, et al.
Cureus|November 26, 2020
Gut-Brain Axis and its Neuro-Psychiatric Effects: A Narrative ReviewLikhita Shaik, Rahul Kashyap, Sahith Reddy Thotamgari, et al.
Therapeutic Advances in Gastroenterology|June 23, 2025
Real-world use of bezlotoxumab to prevent recurrent <i>Clostridioides difficile</i> infections: a single-center experience and meta-analysisKanika Sehgal, Parul Berry, Raseen Tariq, et al.
Pageof 38